Pfizer Inc. (PFE): A Bull Case Theory
Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says
"Florida Discourages Use Of MRNA Covid Vaccines In Older Adults; In Updated Guidance To Health Care Providers, Florida Health Officials Advise That "Non-mRNA Covid-19 Vaccines And Treatment" Should Be Prioritized" - NBC News
US stocks are mixed, with vaccine concept stocks rising and falling, novavax (NVAX.US) up more than 5.4%.
As of press time, the stock has risen more than 5.4%, closing at $12.57.
Novavax COVID-19 Vaccines Now Available
How do you view the recent "hawkish" stance of the Bank of Japan executives? Goldman Sachs: The next interest rate hike may still have to wait until January next year.
Goldman Sachs believes that when evaluating the timing of interest rate hikes, it is important to consider financial market stability and inflation trends. The bank predicts that January next year will be the best time to determine whether Japan's inflation will rebound, and based on this, determine that Japan will raise interest rates in January. However, if there is significant turmoil in the financial markets, the timing of the rate hike may become uncertain.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Deep Sea : Will rise above 30 after the consolidation. It is still undervalued.